

					
						November 22, 2017 - By wolcottdaily
Among 4 analysts covering Swatch (OTCMKTS:SWGAY), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Swatch had 4 analyst reports since October 28, 2015 according to SRatingsIntel. The company was downgraded on Tuesday, November 24 by Nomura. Societe Generale downgraded SWATCH GROUP (OTCMKTS:SWGAY) on Friday, December 11 to “Hold” rating. Deutsche Bank upgraded the stock to “Buy” rating in Wednesday, January 25 report. The company was downgraded on Wednesday, October 28 by BNP Paribas. See SWATCH GROUP (OTCMKTS:SWGAY) latest ratings:Sanofi SA (ADR) (SNY) formed multiple top with $47.48 target or 6.00% above today’s $44.79 share price. Sanofi SA (ADR) (SNY) has $113.32 billion valuation. It closed at $44.79 lastly. It is down 26.96% since November 22, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 2 have Buy rating, 0 Sell and 9 Hold. Therefore 18% are positive. Sanofi-aventis Sa has $56 highest and $50.0 lowest target. $52.67’s average target is 17.59% above currents $44.79 stock price. Sanofi-aventis Sa had 20 analyst reports since October 15, 2015 according to SRatingsIntel. Morgan Stanley upgraded the shares of SNY in report on Thursday, October 15 to “Overweight” rating. Cowen & Co maintained the shares of SNY in report on Tuesday, September 5 with “Hold” rating. The rating was upgraded by HSBC on Wednesday, August 30 to “Hold”. The rating was initiated by Argus Research with “Buy” on Thursday, April 6. On Friday, September 23 the stock rating was initiated by Piper Jaffray with “Neutral”. The rating was downgraded by HSBC to “Hold” on Tuesday, May 3. The firm has “Reduce” rating by HSBC given on Friday, April 7. Berenberg upgraded the shares of SNY in report on Thursday, September 8 to “Buy” rating. The firm has “Mkt Perform” rating by Bernstein given on Monday, November 9. The firm has “Overweight” rating given on Thursday, May 12 by Barclays Capital.Analysts await Sanofi SA (ADR) (NYSE:SNY) to report earnings on February, 14. They expect $0.69 EPS, up 2.99% or $0.02 from last year’s $0.67 per share. SNY’s profit will be $1.75 billion for 16.23 P/E if the $0.69 EPS becomes a reality. After $1.00 actual EPS reported by Sanofi SA (ADR) for the previous quarter, Wall Street now forecasts -31.00% negative EPS growth. It closed at $18.46 lastly. It is down 0.00% since November 22, 2016 and is . It has underperformed by 16.70% the S&P500.By wolcottdailyEchostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.